Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Multiple Sclerosis

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 6 articles: HTML format

Single Articles

May 2025
1. CALABRESI PA
   Progress toward Mitigating Disability Progression in Multiple Sclerosis.
   N Engl J Med. 2025;392:1966-1968.
   PubMed    
   
   
   April 2025
2. FOX RJ, Bar-Or A, Traboulsee A, Oreja-Guevara C, et al
   Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis.
   N Engl J Med. 2025 Apr 8. doi: 10.1056/NEJMoa2415988.
   PubMed     Abstract available
   
   
   
3. OH J, Arnold DL, Cree BAC, Ionete C, et al
   Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis.
   N Engl J Med. 2025 Apr 8. doi: 10.1056/NEJMoa2415985.
   PubMed     Abstract available
   
   
   February 2024
4. HAUSER SL
   Silencing Immune Dialogue in Multiple Sclerosis.
   N Engl J Med. 2024;390:662-663.
   PubMed    
   
   
   
5. VERMERSCH P, Granziera C, Mao-Draayer Y, Cutter G, et al
   Inhibition of CD40L with Frexalimab in Multiple Sclerosis.
   N Engl J Med. 2024;390:589-600.
   PubMed     Abstract available
   
   
   June 2023
6. LEE CD, Galetta SL, Dobson R
   Management of Possible Multiple Sclerosis.
   N Engl J Med. 2023;388:2195-2198.
   PubMed    
   
   

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.